Acute Heart Failure (AHF) Therapeutics Market, by Disorder Type (Right-sided Heart Failure, Left-sided Heart Failure (Systolic Failure, and Diastolic Failure), and Congestive Heart Failure), by Drug Category (Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers, Angiotensin-Receptor Neprilysin Inhibitors, If Channel Blocker, Beta Blockers, Aldosterone Antagonists, Diuretics, Anticoagulants, Cholesterol Lowering Drugs, and Digoxin), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Geography - Size, Share, Outlook, and Opportunity Analysis, 2022-2028
Select a license type that suits your business needs
Single User License
US$ 4,500
US$ 3,500
Three thousand five hundred dollars
Frequently purchased
Multi User License
US$ 7,000
US$ 5,500
Five thousand five hundred dollars
Corporate User License
US$ 10,000
US$ 7,500
Seven thousand five hundred dollars
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients